01387nas a2200469   4500000000100000000000100001008004100002653001500043653001000058653001100068653003000079653003500109653001900144653004700163653003900210653003500249653003400284653002900318653003500347100001000382700001200392700002100404700001100425700001300436700001700449700001600466700001600482700001500498700001000513700001700523700001200540700001300552700002300565700001300588700001500601700002300616245021100639250001500850300001200865490000800877020003200885       2022                            d10aAdolescent10aAdult10aHumans10aAd26COVS1/adverse effects10aBNT162 Vaccine/adverse effects10aCohort Studies10aCOVID-19/epidemiology/prevention & control10a*COVID-19 Vaccines/adverse effects10a*Thrombocytopenia/epidemiology10a*Thromboembolism/epidemiology10a*Thrombosis/epidemiology10aVenous Thrombosis/epidemiology1 aX. Li1 aE. Burn1 aT. Duarte-Salles1 aC. Yin1 aC. Reich1 aA. Delmestri1 aK. Verhamme1 aP. Rijnbeek1 aM. Suchard1 aK. Li1 aM. Mosseveld1 aL. John1 aM. Mayer1 aJ. Ramirez-Anguita1 aC. Cohet1 aV. Strauss1 aD. Prieto-Alhambra00aComparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US  a2022/10/27  ae0715940 v379  a0959-8138 (Print)
0959-8138